Research

Life Sciences & Biotechnology

Title :

IMPAACT 2010, phase III study of the virologic efficacy and safety of dolutegravir-containing versus efavirenz-containing antiretroviral therapy regimens in HIV-1-infected pregnant women and their infants ?VESTED? Virologic Efficacy and Safety of ART Combinations with TAF/TDF, EFV and DTG

Area of research :

Life Sciences & Biotechnology, Medical Sciences

Focus area :

HIV/AIDS/STD

Principal Investigator :

Prof Pradip Sambarey, Byramjee Jeejeebhoy Government Medical College and Sassoon General Hospitals (BJMC), Maharashtra

Timeline Start Year :

2017

Timeline End Year :

2020

Contact info :

Details

Total Budget (INR):

92,19,376

Organizations involved